The Trump administration agreed to drop a controversial pilot that would have allowed drugmakers to give post-sales rebates ...

Many Americans may be unaware that the services they rely on every day through their local hospital are supported by a program called the 340B Drug Pricing Program.

On July 31, 2025, the Health Resources and Services Administration (HRSA) released long-awaited guidance establishing a 340B Rebate Model Pilot Program (Pilot Program). The announcement marks a ...

Henry Ford Health, one of Michigan’s largest 340B health systems, spent $90 million on a naming and branding partnership with ...

The 340B Drug Pricing Program was originally constructed so safety-net health care facilities could stretch scarce resources in caring for low-income patients. However, the program has experienced ...

The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

State lawmakers should stop Big Pharma from jeopardizing rural access to vital medicine by protecting the 340B Drug Pricing ...

The Trump administration's attempt to overhaul how safety net hospitals pay for outpatient drugs has run into a major legal wall, with a federal appeals court keeping a freeze on a controversial pilot ...

Rural hospitals and community health centers are lifelines to the communities they serve. They keep small towns healthy and well, both physically and economically. In New Hampshire alone, hospitals ...

New York state lawmakers are considering a bill that'd make it easier for big hospital systems to siphon off financial aid that's meant for poor patients. The bill involves the 340B Drug Pricing ...

I woke up in a hospital to learn I was given a new name. Almond T. Rectangle. In May 2024, I suffered a cardiac arrest while less than 40 miles away from my home in Brunswick. I don’t remember any of ...

On September 12, 2025, the United States Court of Appeals for the Fifth Circuit, in AbbVie v. Fitch, Case No. 24-60375, (5th Cir. 2025), affirmed a federal District Court’s denial of a preliminary ...